受者

shòu zhě
  • Recipient;receptor
受者受者
受者[shòu zhě]
  1. 观察表明,骨髓移植时供者KIR表型与受者HLA表型可影响骨髓移植的预后。

    Clinic observation proves that the prognosis of bone marrow transplantation can be affected by the KIR phenotype of donor and HLA phenotype of the receptor .

  2. 在这个过程中,译者充当受者角色。

    In this process , the translator plays the role of a receptor .

  3. 器官移植术后受者人巨细胞病毒的PCR检测

    Detection of human cytomegalovirus by PCR after organ transplantation in recipients

  4. 受者术中预置右侧肾脏血管体外结扎线,术后3d结扎。

    Extracorporeal ligation of the native renal vessels was applied 3 days later after transplantation .

  5. 结论HBV及HCV感染显著影响肾移植受者的长期存活率;

    Conclusions HBV and HCV infection could significantly lower the survival of renal transplantation patients .

  6. 肾移植供、受者HLA-DR血清学分型414例结果分析

    Analysis of HLA-DR typing by standard serology in 414 individuals of donor-recipients of cadaveric transplantation

  7. 因此,移植成功的重要前提是要对供-受者HLA进行精细的分型。

    Therefore , the important premise of successful transplantation is subtle HLA typing for donor-recipient pairs .

  8. 目的探讨吞噬供体凋亡细胞的受者树突状细胞(DC)的功能及其在诱导同种异体小鼠心脏移植耐受中的作用。

    Objective To investigate the effect of recipient dendritic cells ( DC ) loaded with donor-derived apoptotic cells on inducing murine cardiac allograft tolerance .

  9. 异基因骨髓移植中供者TNFα-308(G/A)基因型与受者急性移植物抗宿主病的关系

    The relationship between donor TNF α - 308 ( G / A ) genotype and recipient acute GVHD in allo-BMT

  10. 方法将1286例次肾移植受者,按HLA误配率(MM)进行分组;

    Methods The 1286 recipients undergoing kidney transplantation were randomly grouped in terms of the HLA mismatching frequency ( MM ) .

  11. 方法:以Fisher大鼠作供者,Lewis大鼠作受者进行同种肾移植。

    Method : Renal transplantation was performed with Fisher rats as donors and Lewis rats as recipients .

  12. 目的:探讨肝移植(OLT)受者环孢素A(CsA)合理的血药浓度监测指标。

    OBJECTIVE To investigate the blood level monitoring of CsA for liver transplantation patients .

  13. US的这种需求和意图,随着受者军产复合体等战争狂支援的Bush登场,成为了现实。

    With the debut of Bush who are greatly backed by such crazy war-fighter as the complexity of military and productive industries , the requirements and intentions of US come into reality .

  14. 方法采用X、Y染色体探针和间期双色间期FISH法检测35例异性异基因造血干细胞移植受者移植后不同时期的性染色体荧光杂交信号。并设对照组,分析检测的有效率。

    Method The fluorescence signal of samples from 35 cases in different periods after sex-mismatched allo-HSCT were detected by interphase FISH using chromosome enumeration probes ( CEP ) X and Y.

  15. 目的探讨肾移植受者术后早期巨细胞病毒(CMV)感染与远期慢性移植肾肾病的关系。

    Objective To investigate whether cytomegalovirus ( CMV ) infection is associated with chronic allograft nephropathy ( CAN ) .

  16. 获取受者及其同胞供者的DNA,通过变性高效液相色谱(DHPLC)法结合DNA测序检测TNF-d基因型。

    TNF-d genotype was analyzed by DHPLC ( denature high performance liquid chromatography ) and DNA sequencing .

  17. 本资料分别探讨了不同高危受者术后应用CsA免疫抑制治疗的特点。

    The characters of CsA immunosuppressive treatment at the early stage of post transplantation were discussed among different high risk uremia .

  18. 骨髓间充质干细胞(MesenchymalStemcells,MSC)体外具有造血支持作用,与CD34~+细胞共输入受者体内可以促进HSC向骨髓、脾等造血部位的植入。

    Previous data have demonstrated that mesenchymal stem cells ( MSC ) support in vitro hematopoiesis and promote the engraftment of HSC to bone morrow and spleen as well .

  19. 方法在传统HLA配型以及淋巴毒试验的基础上,对21例高致敏受者(PRA>40%)进行严格的HLA特异性抗体分析以及交叉反应组配型分析。

    Methods On the base of traditional HLA matching and microcytotoxicity assay , to analyze strictly HLA specific antibody and CREGs matching of 21 recipients ( PRA > 40 % ) .

  20. 结论:PRA的检测是肾脏移植术前筛选致敏受者的重要指标,对肾脏移植后排斥反应和移植物存活率关系密切。

    Conclusion PRA is an important indicator of possible sensitization to a graft and is closely related to the success or failure of the transplantation operation .

  21. 目的探讨应用GCSF动员外周血干细胞时,异体自体造血干细胞移植供受者的骨髓及外周血CD34+细胞和T细胞亚群的动态变化特点及最佳外周血干细胞采集时间。

    Objective To explore the dynamic changes of CD34 + cells and T lymphocyte subsets and best time of harvesting peripheral blood stem cell when G-CSF was used for peripheral blood stem cell mobilization in donors and patients .

  22. 以NIH-CDC阴性为入选标准的34例临床移植中,接受Flow-CDC阴性供肾的受者33例,术后仅1例+5d出现急性排斥经冲击治疗后逆转,Scr平均恢复时间为+6d;

    In 33 recipients who received NIH-CDC and Flow-CDC both negative transplantation , 1 suffered from acute rejection .

  23. 方法:受者鼠为Balb/c小鼠,供者鼠为C57bl/6小鼠,依据不同DLI将受者鼠随机分为A、B、C、D和E5组,每组5只。

    Methods : Recipient mouse was Balb / c and donor was C57bl / 6.Twenty five recipient mice were divided into A 、 B 、 C 、 D and E group according to different DLI randomly .

  24. 当肾移植受者有CD3阳性T淋巴细胞、CD4阳性T淋巴细胞、CD56阳性T淋巴细胞、血清肌配或谷丙转氨酶的异常时应考虑CMV感染。

    It is essential to bethink of CMV infection when CD3 + T lymphocytes , CD4 + T lymphocytes , CD56 + T lymphocytes , creatinine or alanine aminotransferase of renal transplant recipients are abnormal .

  25. 目的利用眼镜蛇蛇毒因子(CVF)、全身照射(WBI)、异基因胸腺修饰等途径预处理受者,探讨这些处理对非协调性异种心脏移植物存活期及免疫排斥反应的影响。

    Objective To investigate the effect of CVF , whole body irradiation and intrathymic inoculation with xenogeneic antigen on the delayed xenograft rejection in the discordant cardiac xenotransplantation .

  26. 方法:采用单克隆抗体一步法和顺序特异引物聚合酶链反应技术(PCR-SSP),对78例肾移植受者进行随机性HLA-A、B、DR位点配型。

    Methods : HLA A , B , DR matching by one step monoclonal antibody and polymerase chain reaction with sequence specific primers ( PCR SSP ) were made for 78 randomly selected donor recipients of cadaveric renal transplantation .

  27. 然而抗体阳性组受者移植物功能延迟恢复(DGF)的发生率显著高于阴性组受者(P<0.001)。

    However , the incidence of developing the delayed graft function ( DGF ) in positive recipients was significantly higher than that in negative ones ( 33.9 % vs 11.9 % , P < 0.001 ) .

  28. 防止肾移植术后CMV感染关键在于对高危人群的早期诊断和预防,肾移植术后对CMV血清学D+/R-或D±/R+受者使用万乃洛韦90天是一种预防CMV感染安全、有效的方法。

    Early diagnosis and prophylaxis of CMV high-risk group are the key points for preventing CMV infection after renal transplantation . To D + / R - or D ± / R + recipients using valaciclovir for 90 days is a safe and efficient method for preventing CMV infection .

  29. 结果:输注MSCs后20d,受者淋巴细胞与供者皮肤呈现减低的免疫反应,皮肤病理损伤程度较输注前减轻,凋亡细胞比例由(23.0±4.9)%下降到(12.2±1.9)%;

    Results : Twenty days after infusion , the pathological lesion in in vitro skin explants from MSCs donor was less and the apoptosis rate was declined to ( 12.2 ± 1.9 ) % from a pre-infusion level of ( 23.0 ± 4.9 ) % .

  30. 20例肺移植受者选择的体会

    Some experiences with the selection of twenty lung - transplant recipients